A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 139.14
GOOG 843.25
MSFT 64.93
BAC 25.31
FB 138.79

Recently Added

PANW 118.88
STRL 9.92
LAYN 9.06
NOA 4.70
LL 17.84

Gaining Speed

LL 17.84
NOA 4.70
LAYN 9.06
PANW 118.88
STRL 9.92
33.39 +0.43 (1.29%) TEVA

Click Here to Receive Instant E-mail and RSS Alerts


Trade TEVA now with

Stock Details

Last Trade:33.39 Change:+0.43 (1.29%) Prev Close:32.96 Open: 33.35 Days Range:33.07 – 33.54 52 Week Range: 37.82 - 66.55 Volume:4234161 P/E: N/A
EPS:0.00

Member Comments

No member comments available for TEVA


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 03/11/17

Recent Alert on 03/08/17 at 7:56am
Tepper Trims Stake in Allergan (AGN), Comments on Teva (TEVA)

On CNBC, David Tepper said he sold a portion of his Allergan (NYSE: AGN) stake as the stock climbed higher but still owns about 80%. On Teva (NASDAQ: TEVA), Tepper said it wasn't one of their best picks give execution issues, competition and worries... Read More

Recent Alert on 03/08/17 at 7:02am
Supernus Pharmaceuticals (SUPN) PT Raised to $35 at Jefferies Following Zydus Settlement with Teva Pharmaceuticals (TEVA)
Recent Alert on 03/07/17 at 1:08pm
Supernus Pharma (SUPN) Enters Trokendi XR Settlement with Actavis
Recent Alert on 03/07/17 at 7:19am
Jefferies Reiterates Buy Rating and $33 PT on Supernus Pharmceuticals (SUPN) Following Zydus Settlement; Teva Pharma (TEVA) Shoud Be Next
Recent Alert on 03/01/17 at 10:57am
Teva Pharma (TEVA) Launches Generic Pristiq in U.S.

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 08/07/13 at 2:44pm
Endo Health Has A Lot Of Work To Do
Blog Posts on 08/06/13 at 9:28am
Antares Pharma's Otrexup Will Gain FDA Approval And Generate Positive EPS
Blog Posts on 08/05/13 at 6:34pm
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Blog Posts on 08/01/13 at 12:41pm
Teva Pharmaceutical's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Blog Posts on 08/01/13 at 8:01am
Teva Pharmaceutical Industries Limited (TEVA) Management Discusses Q2 2013 Results (Webcast)